All News
Filter News
Found 808,979 articles
-
Roivant Sciences Announces Change to its Board of Directors
2/22/2023
Roivant Sciences announced that its founder Vivek Ramaswamy has stepped down from the company’s board of directors to focus on his U.S. presidential campaign.
-
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
2/22/2023
10x Genomics, Inc. announced the company will be participating in the upcoming 43rd Annual Cowen Healthcare Conference in Boston, Massachusetts.
-
Poseida Therapeutics Hosts Third Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations
2/22/2023
Poseida Therapeutics, Inc. today announced that the Company plans to highlight its clinical and preclinical pipeline progress during a virtual R&D Day to be held today at 10:00am ET / 7:00am PT.
-
Team Aims to Transform Care for Diffuse Intrinsic Pontine Glioma
2/22/2023
Researchers at Children’s Hospital Los Angeles have received a nearly $1 million K08 grant from the National Institutes of Health —as well as funding from the U.S. Department of Defense—to support studies into diffuse intrinsic pontine glioma, a childhood brain tumor with a 0% survival rate.
-
Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023
2/22/2023
Beyond Air, Inc. and, through its affiliate Beyond Cancer, Ltd. announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in two upcoming investor conferences in March 2023.
-
Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions
2/22/2023
Trinity Biotech plc announced its entry into an increased loan facility to fund potential acquisitions and ongoing operations.
-
NanoVibronix to Launch Rental Program for PainShield and UroShield
2/22/2023
NanoVibronix, Inc., a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, announced that it intends to launch a month to month rental program on March 1, 2023 for its lead products, PainShield and UroShield.
-
TransCode Therapeutics and BRAIN Biotech join forces to develop a CRISPR-derived technology platform for cancer treatment
2/22/2023
TransCode Therapeutics, Inc. today announced the signing of a non-binding letter of intent and a joint research and development agreement (JDA) with industrial biotechnology and genome editing expert, BRAIN Biotech AG.
-
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
2/22/2023
Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company, announced the release of its inaugural Environmental, Social and Governance report.
-
Northwind Pharmaceuticals Adds Health Intelligence Innovator Rod Reasen to Advisory Board
2/22/2023
Northwind has announced the addition of Rod Reasen to its strategic advisory board.
-
Advocating for Alzheimer's Patients: Dr. Christopher Hancock Wins Leadership Award for Outstanding Contributions
2/22/2023
HALO Precision Diagnostics™ announced Christopher Hancock, MD, HALO's neuroscience innovation officer, will receive the Edie Keller Leadership Award for his outstanding contributions to Alzheimer's disease patient advocacy and clinical education from Alzheimers Coachella Valley at its annual Endless Possibilities event.
-
Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
2/22/2023
Quoin Pharmaceuticals Ltd. today announced the pricing of its "reasonable best efforts" public offering of 24,750,000,000 ordinary shares.
-
Spectrum Solutions Receives FDA 510(k) Class II Medical Device Clearance for SDNA Saliva Collection Device
2/22/2023
Spectrum Solutions today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) Class II clearance to the SDNA Saliva Collection Device as a microbial nucleic acid storage and stabilization device.
-
Sinovac Amends Shareholder Rights Plan - February 22, 2023
2/22/2023
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its board of directors has amended its shareholder rights plan.
-
Primordial Genetics Launches High-Performance RNA Polymerases
2/22/2023
Primordial Genetics, Inc., a synthetic biology company, announced the launch of its proprietary RNA polymerases to advance safe, viable mRNA-based vaccines and therapeutics.
-
4D Molecular Therapeutics Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials & Development Plans for Fabry Disease Cardiomyopathy at WORLDSymposium™
2/22/2023
4D Molecular Therapeutics (Nasdaq: FDMT, ‘4DMT’), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, today announced updated interim safety and efficacy data from the two 4D-310 INGLAXA Phase 1/2 clinical trials for Fabry disease cardiomyopathy.
-
ORYZON Hosting Key Opinion Leader Webinar on Targeting Lysine Specific Demethylase 1 (LSD1) in CNS and Psychiatric Disorders and Oncology
2/22/2023
Oryzon Genomics, S.A. announced that it will host a virtual panel discussion, featuring Dr. Dyanna Phillips Domilici, Dr. med. Peter Hahn, and Dr. Olga Salamero, discussing the unmet medical needs in specific central nervous system and oncology diseases.
-
Thermo Fisher Scientific Increases Quarterly Dividend - February 22, 2023
2/22/2023
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per common share payable on April 14, 2023, to stockholders of record as of March 15, 2023.
-
Agilent Announces Cash Dividend of 22.5 Cents Per Share - February 22, 2023
2/22/2023
Agilent Technologies Inc. announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of business on April 4, 2023.
-
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
2/22/2023
Ajinomoto Bio-Pharma Services is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity.